Nephros (NEPH)

Nephros also serves commercial markets with filtration systems that improve water quality for equipment and end users. Its filters are used to reduce taste and odor issues, limit biofilm and bacterial build-up, and help control scale in downstream equipment. These capabilities make the company relevant to food service, hospitality, office beverage systems, and other settings where water affects product quality, equipment performance, and maintenance costs.

The company generates nearly all of its revenue from product sales, with a smaller contribution from royalties and other sources. This makes sales execution, distribution relationships, product reliability, and regulatory or compliance requirements important factors for its business.

Nephros also has a subsidiary focused on renal disease therapies, including development work related to a second-generation hemodiafiltration system and other products intended to improve treatment options for patients with kidney disease. This gives the company exposure not only to water filtration and safety, but also to specialized medical technology. Nephros’ distinguishing focus is the use of advanced filtration to address both clinical water risks and commercial water quality challenges.